RBRK241220C72500
- 2.25
- -1.56-40.94%
Rubrik Newsroom
Rubrik Is Maintained at Outperform by Mizuho
Rubrik Analyst Ratings
Mizuho Securities Maintains Rubrik(RBRK.US) With Buy Rating, Raises Target Price to $75
Truist Financial Maintains Rubrik(RBRK.US) With Buy Rating, Maintains Target Price $75
Truist Financial Sticks to Their Buy Rating for Rubrik, Inc. Class A (RBRK)
Rubrik Is Maintained at Outperform by Mizuho
Mizuho Securities Maintains Rubrik(RBRK.US) With Buy Rating, Announces Target Price $68
A Quick Look at Today's Ratings for Rubrik(RBRK.US), With a Forecast Between $72 to $76
Rubrik Is Maintained at Buy by Citigroup
Rubrik Is Maintained at Overweight by Barclays
Rubrik Price Target Raised to $70.00/Share From $58.00 by Cantor Fitzgerald
Truist Securities Maintains Buy on Rubrik, Raises Price Target to $75
A Quick Look at Today's Ratings for Rubrik(RBRK.US), With a Forecast Between $55 to $76
Rubrik Is Maintained at Overweight by Keybanc
Deutsche Bank Raises Rubrik Price Target to $65 From $46, Maintains Buy Rating
Analysts Offer Insights on NA Companies: Rubrik, Inc. Class A (RBRK) and CG Oncology, Inc. (CGON)
Rubrik Is Maintained at Outperform by Baird
Rubrik Analyst Ratings
Baird Maintains Outperform on Rubrik, Raises Price Target to $55
KeyBanc Maintains Rubrik(RBRK.US) With Buy Rating, Raises Target Price to $57